Advancing PoC Devices for Early Disease Detection using

Graphene-based Sensors by Oshin, Oluwadamilola et al.
Journal of Physics: Conference Series
PAPER • OPEN ACCESS
Advancing PoC Devices for Early Disease
Detection using Graphene-based Sensors
To cite this article: Oluwadamilola Oshin et al 2019 J. Phys.: Conf. Ser. 1378 032031
 
View the article online for updates and enhancements.
Recent citations
Human virus detection with graphene-
based materials
Eleni Vermisoglou et al
-
This content was downloaded from IP address 165.73.192.252 on 28/04/2021 at 15:47
Content from this work may be used under the terms of the Creative Commons Attribution 3.0 licence. Any further distribution
of this work must maintain attribution to the author(s) and the title of the work, journal citation and DOI.
Published under licence by IOP Publishing Ltd
International Conference on Engineering for Sustainable World











Advancing PoC Devices for Early Disease Detection using 
Graphene-based Sensors 
Oluwadamilola Oshin1, Dmitry Kireev2, 3, Deji Akinwande2, 3, Emmanuel Adetiba1, 4, 
Francis Idachaba1 and Aderemi Atayero1 
1 Electrical and Information Engineering Department, Covenant University, Ota, Ogun State, Nigeria. 
2 Department of Electrical and Computer Engineering, University of Texas at Austin, USA. 
3 Microelectronics Research Center, University of Texas at Austin, USA. 
4 HRA, Institute for Systems Science, Durban University of Technology, Durban, South Africa. 
 
Corresponding Author: damilola.adu@covenantuniversity.edu.ng 
Abstract. Early detection of diseases is key to better disease management and higher survival 
rates. It aims at discovering conditions that have already produced biochemical changes in 
body fluids, but have not yet reached a stage of apparent physical symptoms or medical 
emergency. Therefore, early disease detection relies majorly on biochemical testing of 
biological fluids such as serum, in the body. The laboratories for these tests require 
biochemical-based instrumentations that are bulky and not commonly available especially in 
developing countries. Moreover, the tests are expensive and require trained personnel to 
conduct and interpret results. On the other hand, Lab-on-a-Chip (LOC) biosensors have a 
potential to miniaturize the entire biochemical/laboratory methods of diagnostics into 
versatile, inexpensive and portable devices with great potential for low-cost Point-of-Care 
(POC) applications. They are capable of providing accurate and precise information on the 
measured health indices for sub-clinical level of diseases. Nanotechnology-inspired 
biosensors have further advantages of low limit of detection (required for early diagnosis), 
real-time analysis and lesser sample volume requirement. Of all other nanomaterials, 
graphene is said to be the most promising, suitable for biosensing due to its biocompatibility 
and consistent signal amplification even under the conditions of harsh ionic solutions found 
in the human body. This paper reviews the potentials, fundamental concepts and related 
works in using Graphene-based Field Effect Transistors (GFETs) as biosensors for early 
disease diagnosis. This paper also highlights a low-cost patterning mechanism for preparing 
SiO2/Si substrate for metal deposition (of the source and drain electrodes of FETs). 
Keywords: Biosensors, Early Detection, Graphene, GFET, Lithography, Nanotechnology, 
POC, Shadow mask  
1. Introduction 
According to the United Nations Development Programme (UNDP), good health and well-being 
(SDG3) is critical for the attainment of the remaining 16 sustainable development goals (SDGs) and 
consequently the UN 2030 Agenda [1].  Significant research progress has been made against several 
leading causes of diseases and deaths worldwide, even though this progress varies widely within 
individual countries and also among countries. However, the world is still generally off-track in 
achieving the health-related SDGs. In addressing the global health challenges, a lot of emphasis is 
currently being placed on prevention and early stage detection of diseases as one of the ways forward 
[2], [3]. Early disease detection relies heavily on biochemical testing of biological samples in the 
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appropriate laboratories. Most of these tests depend on optical imaging using a fluorescent material, 
such as in Enzyme-Linked Immunosorbent Assay (ELISA) or the chromatographic technique called 
High Performance Liquid Chromatography (HPLC) that rely on the interaction of various components 
of an analyte with the solid adsorbent material within its column. Although these methods have high 
sensitivity and specificity, they require complex, bulky, and expensive instrumentation that are not 
commonly available in primary laboratories especially in developing countries. They also require highly 
professional knowledge and techniques to conduct experiments and interpret results. These challenges 
severely impede frequent health monitoring, prompt interventions that may succeed early diagnosis of 
diseases, point-of-care monitoring of treatment, monitoring of disease regression/ progression and 
others. Therefore, a lot of research is directed towards the development of test devices that can be used 
conveniently and reliably at the Point-of-Care (POC) [4]–[7]. It is noteworthy that the World Health 
Organization (WHO) already identified the place of such methods in diagnostics and have set out the 
ASSURED (Affordable, Sensitive, Specific, User-friendly, Rapid and robust, Equipment-free and 
Deliverable to end-users) criteria to be used as a benchmark for developing the most suited test method 
in resource-constrained situations [8]. Although developed by the Sexually Transmitted Diseases 
Diagnostics Initiative (SDI) of WHO [8], the ASSURED criteria is beginning to find a wider relevance 
as it is being applied to varied diseases. Biosensors have the potential to satisfy most/all of these criteria. 
They are capable of providing accurate/ precise information on the desired measured health indices as 
well as sub-clinical level of diseases [9], [10].  Biosensors based on label-free electrical detection 
methods, especially Field Effect Transistors (FETs) based ones, offer the most feasible POC test setup 
due to their cost-effectiveness, simplicity, fast response and low power requirement while offering high 
sensitivity and selectivity. Achieving more compactness facilitated by miniaturization of biosensors, is 
enabled by nanotechnology. This offers additional benefits including: low limit of detection (required 
for early diagnosis), real-time analysis and lesser sample volume requirement [4], [11]. The defining 
principle of nanotechnology is that as the size of materials reduce towards this nanoscale, the number 
of atoms at the surface of the material significantly increases compared to the bulk of the material. This 
phenomenon results in a large surface area to volume ratio.  Most of the desirable properties of sensors 
are due to this large surface area to volume ratio.  
Since the first exfoliation of a single atomic layer of graphene in 2004 by Geim and Novoselov [12], 
of all other nanomaterials, it is said to be the most promising nanostructured carbon material suitable 
for biosensing and has been under intense research for over a decade [11], [13]. Graphene is 
biocompatible and still produces signal amplification even under the conditions of harsh ionic solutions 
found in the human body [14]. Unlike the conventional silicon-based Metal Oxide Semiconductor FET 
(MOSFET), using graphene as a channel is increasingly being explored as a new category of 
nanoelectronic neuro- and bio-sensors [15], [16]. These sensors mostly rely on charge detection – where 
the analyte and sensor interaction changes the charge density in the vicinity of the nanomaterial. This in 
turn produces an electrically measurable signal through charge transfer between the biomolecules and 
the nanomaterial. This is possible because the charge carrier density of the nanomaterial can be varied 
by doping [17]; therefore, the adsorption of the analytes while appropriately modulating the gate voltage, 
produces the change in charge density. This paper details the fundamentals in using graphene in FETs 
for biosensing and also presents a low cost patterning mechanism for preparing SiO2/Si substrate for 
metal deposition (of the source and drain electrodes of FETs). 
2. Graphene 
Graphene is an atomically thin carbon based nanomaterial [18]. The main derivatives of graphene are: 
graphene oxide, reduced graphene oxide and graphene-based quantum dots. Graphene is a sheet made 
up of carbon atoms arranged in a honeycomb-shaped lattice of sp2-hybridized carbon [19]. The geometry 
of graphene presents a very high surface to volume ratio, since it is only one atom thick [20], [21], 
therefore, exposing a significant portion of the surface area for detection of analytes (an advantage over 
other nanostructures in FET-based sensor designs). Graphene has no band gap and offers notable 
advantages of: carrier mobility (~200,000cm2/V/s), electrical conductivity (~104 S/cm), optical 
transmittance and Young’s modulus of ~1 TPa [22]. It also exhibits ambipolar electric field effect such 
that it is able to detect both positive and negatively charged biomolecules [23].  
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Graphene synthesis can be categorized into: top-down and bottom-up approaches [24]. The focus of 
top-down approaches are aimed at reducing bulky and layered graphite compounds into mono and few-
layer graphene since the compounds are made up of single-layer graphene with weak van der Waals 
interactions between adjacent layers. The focus of the bottom-up approach is to grow the required 
number of graphene layers. Several variants based on these two broad categories have been 
demonstrated; however, the four most used methods are: mechanical exfoliation of graphite, Chemical 
Vapour Deposition (CVD), graphitization of Silicon Carbide (SiC) surface and thermal reduction of 
graphite oxide [25], [26]. Graphene is now widely commercially available in form of graphene on copper 
foil (Gr/Cu) most of which are synthesized using CVD. 
3. Fabricating Graphene Biosensors 
Fabrication of graphene-based biosensors follow three major steps as seen in figure 1:  
• Step 1 – graphene preparation for use in the biosensor (assuming graphene is purchased as Gr/Cu). 
This represents the process of preparing graphene for transfer from the copper foil to the desired 
substrate.  
• Step 2 – substrate preparation. In this step, the resulting graphene from step 1 is transferred onto 
the resulting chip from step 2 before functionalization. 
• Step 3 – functionalization of the resulting graphene transistor from step 2. This simply refers to 
the steps taken to attach the bio-receptor (antibodies, aptamers, nucleic acids etc.) specific to 
the target analyte to the graphene layer. It can be done covalently or non-covalently, each with 








•Cut the Gr/Cu into desired dimensions.
•Deposit (spincoat) a protective polymer (e.g. PMMA) on Gr/Cu.
•Anneal (temperature and duration depend on application area).
•Place PMMA/Gr/Cu into the etching solution (e.g. APS - (NH4)2S2O8) to 
remove the underlying Cu layer.
•Triple wash the PMMA/Gr in clean DI water .
Substrate/ Chip 
Preparation
•Pattern creation (designing) and transfer to lithography tool (photo/ e-
beam lithography).
•Evaporate metal (e.g. Ni/Au) on the subsrtrate though the pre-fabricated 
shadow mask to create pattern.
•Transfer graphene on top and remove PMMA.
Functionalization
•Covalent - Firstly, oxygen functional groups are introduced to the 
graphene lattice to create binding sites, followed by direct attachment of 
bioreceptors to the GO or rGO surface, in effect introducing defects and 
tampering with the electrical performance of the pristine graphene. 
•Non-covalent - has the significant advantage of preserving the graphene 
structure, and in effect, the electrical features by using appropriate linkers 
between the graphene surface and the bioreceptors. 
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Functionalization essentially “gives life” to the biosensor. It defines the application of the biosensor 
where biomarkers specific to a condition are targeted and immobilized on the sensor using the 
appropriate chemicals and biomolecules. Table 1 presents several graphene-based biosensors reported 
in the literature; showing different substrate types, linkers, measurement setups, different forms of 
graphene and their respective performances (SE – sensitivity, SP – specificity, DL – detection limit, R 
– range & RT – response time). After fabrication, measurements are carried out. FET-based 
measurement setups (as shown in figures 2a-d) can either be carried out in vacuum using the back-gated, 
top-gated, dual-gated configurations, or modifications of these three as presented in literature or in an 




Figure 2. The GFET measurement setup in (a) represents a back-gated GFET; (b) represents a top-gated 
GFET; (c) represents a dual-gated FET, where the top-gate can also be a liquid-gated FET like in (d); 
(d) represents a liquid or electrolyte-gated FET 
3.1. Low-cost patterning procedure for shadow masks 
Lithography is a state-of-the-art method required to transfer desired patterns to a desired substrate using 
a mask. There are several types of lithography but the most common ones are ultraviolet (UV) 
lithography and electron beam (e-beam) lithography. Lithography is a complex procedure and highly 
error-prone; therefore, care must be taken in following through its requirements to obtain workable 
results. While UV and especially e-beam lithography can provide extremely good and reproducible 
patterns down to 1 µm and 1 nm respectively, they are also time consuming and expensive. Presented 
here is an alternative route to lithography and a simple approach to preparing shadow masks that can be 
used to cover a SiO2/Si wafer in preparation for metal deposition of source and drain contact electrodes. 
 
3.1.1. Methodology. The method is based on off-the-shelf commercially available mechanical plotter, 
Silhouette Cameo that is able to cut through a set of polymers or papers with reliably good feature sizes, 
down to 100 µm.  To start with, an array of InterDigitated Electrode (IDE) structure was designed and 
arranged specifically to cover and align to crystallographic planes of a 4-inch silicon wafer diameter 
using the Silhouette Studio software as seen in figure 3a. The paper was then stuck to the Silhouette 
Cameo printing mat and tuned to the appropriate settings to print the desired pattern. After printing with 
the dice from the Cameo plotter, the mask was manually removed with the aid of a tweezer. Figure 3b 
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Figure 3. The Silhouette Studio layout of the IDE-structured mask is seen in (a); (b) shows the Silhouette 
Cameo plotter-printed mask with some of the IDE structure exposed. 
 
After exposing the IDE structures representing individual transistors throughout the shadow mask, it 
is then held in place on the substrate (SiO2/Si wafer) using kapton tape. The procedure for metal 
deposition using the CHA Evaporator is followed through to deposit a thin layer of Ni (10 nm) and Au 
(90 nm). Nickel is deposited first to serve as an adhesion layer, while gold is the metal contact serving 
as source and drain for the transistor.  
 
3.1.2. Results and Discussion. Figure 4 shows some of the transistors realized from this process after 
breaking up the wafer into the individual IDE-structured transistors using a diamond scribe.  
 
 
Figure 4. IDE-structured FETs fabricated 
using the low-cost mask patterning method. 
 
We further tested the performance of these devices based on a liquid-gated GFET setup shown in 
figure 2d, using 0.01X PBS (~1.5mM ionic strength) as the electrolyte and a Keithley 2602A Source 
Measure Unit (SMU) coupled with a probe station. Figure 5 depicts the response of one of the devices 
showing the ambipolar nature of graphene and a p-type device. 
(a) (b) 
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4. The Electrical Double Layer (EDL) of GFETs 
Conventional graphene-based back gates FETs operate in the atmosphere and the field effect is 
introduced via application of potential through bulk silicon and accumulation of charges through the 
substrate dielectric (typically SiO2). To build a reliable GFET biosensor, the gate oxide layer is replaced 
by an electrolyte in which the sensing takes place (see figure 2d). When a potential is applied between 
graphene channel and liquid gate (through electrolyte), an electrical double layer is formed at the 
interface according to the Helmoltz-Gouy-Chapman-Stern theories [27]–[30]. This setup is similar to 
the dielectric material for capacitors and the gate oxide for MOSFETs. This interface between the 
channel and the electrolyte is called the Electrical Double Layer (EDL), and it is understood and 
computed as a parallel-plate capacitor with a capacitance of CEDL. CEDL is then connected in series with 
the air-gap capacitance (Cair-gap, occurs due to the hydrophobic nature of graphene) and the graphene’s 
inherent quantum capacitance (Cq) to obtain the total gate capacitance of the device as shown in figure 
6 [31]. As a result, modulation of the graphene channel potential through the gate electrode occurs 
through capacitive processes, and the amount of voltage required to operate the device is typically within 
1V which constitutes a very low power operation. The EDL is therefore the distance from the graphene 
surface, with a thickness equal to the Debye length (𝜆𝜆𝐷𝐷) which is defined by the electrolyte’s molarity 
(𝑀𝑀), as seen in equations (1) and (2).  
 
𝐶𝐶𝐸𝐸𝐷𝐷𝐸𝐸 = 𝜖𝜖0𝜖𝜖𝑟𝑟(𝜆𝜆𝐷𝐷)−1     (1) 
 
𝜆𝜆𝐷𝐷 = 0.304(√𝑀𝑀)−1 [𝑛𝑛𝑚𝑚]    (2) 
 
 
Figure 6. A liquid-based GFET 
biosensor highlighting the EDL 
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Upon immobilization of the sample (the electrolyte) containing the desired analytes to bind with their 
bioreceptors on the graphene layer, there is a change in surface charge. Electronic changes resulting 
from binding interactions will only occur within the Debye length. Therefore, the target analytes must 
be sufficiently (as defined by 𝜆𝜆𝐷𝐷) close to the sensor surface in order to trigger a response [32]. This is 
what brings some difficulty in liquid-based GFETs because the process to functionalize the GFET incurs 
some height, where typical heights of antibodies is 5 – 10nm and 10 – 15nm [5]. Also, from equation 
(2), it can be deciphered that the higher the molarity, the shorter the Debye length. For example, the 
electrolyte solution Phosphate Buffered Saline (PBS) of approximate molarities 150mM, 15mM and 
1.5mM correspond to Debye lengths of 0.7nm, 2.3nm and 7.3nm respectively [5], [15], [33]. Therefore, 
there must be significant consideration in materials used to functionalize the graphene surface as well 
as the electrolyte’s molarity to avoid electrostatic charge screening of the analytes. 
 
5. Considerations for POC Testing 
Graphene has great potentials in satisfying the ASSURED criteria of diagnostic devices. However, the 
measurement setup will largely influence the possibility of POC applications. With respect to the 
literature reported in table 1, there are three categories of sensors. References [34]–[41] detail liquid-
gated FET configurations, [42], [43] report in-situ analyte measurement (liquid-based) using back-gated 
FET while other works reported dry (vacuum/ ambient conditions-based) measurements. In liquid-based 
FET setup, measurement is carried out while the sample containing the analyte is dispensed on the sensor 
surface, while in the third category, the sample containing the analyte is incubated on the sensor surface 
to allow antigen-receptor binding for a given amount of time (typically 30 minutes – 1 hour), followed 
by rinsing and drying of the chips and then measurements. In effect, biosensors based on the liquid-
gated configuration are better positioned to fulfill the ASSURED criteria, specifically in User-
friendliness and Equipment-free criteria. They also have lower energy requirement as mentioned earlier. 
On the other hand, “dry” measurements circumvent electrostatic charge screening due to Debye 
length/EDL, since the graphene channel potential is modulated through the substrate and not electrolyte. 
 
Table 1. Graphene-based Sensors 
 
Sensor 
















Heart failure BNP SiO2/Si + RGO + PtNPs + 
anti-BNP (a silver wire 
reference electrode was 
used to realize a liquid-
gated FET) 





Glass + RGO + PASE + 
PSA monoclonal 
antibody (a platinum 
reference electrode was 
used to realize a liquid-
gated FET) 





Lead Pb2+ SiO2/Si + G + PASE + 8–
17 DNAzyme (a gold 
wire was used to realize a 
liquid-gated FET) 
37.5ng/L –  [36] 
DNA DNA SiO2/Si + RGO + PASE + 
PNA (a silver wire 
reference electrode was 
used to realize a liquid-
gated FET) 
100fM –  [37] 
Cancer miRNA SiO2/Si + RGO + AuNPs 
+ PNA (a silver wire 
10fM –  [38] 
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reference electrode was 





DNA SiO2/Si + SLG + PASE + 
probe DNA 
(Electrolyte-gated) 
25aM SE – 
24mV/dec 
[39] 
Diabetes GOx Glass + SLG + (GOx-
CHIT/Nafion/PtNPs/grap
hene electrode)  
0.5µM 0.5µM to 
1mM 
[40] 
Zika Virus Zika 
NS1 
SiO2/Si + SLG + anti-
Zika NS1 monoclonal 
antibody 
















s EVD EGP of 
the Zaire 
strain 
SiO2/Si + RGO + AuNPs 
+ anti-Ebola probes 
1ng/mL a few secs 
SE – 6.5% 









E.coli SiO2/Si + TRMGO on 
AET-modified Au 
(source & drain) 
electrodes + AuNPs + 
anti-E.coli antibodies 















Pregnancy hCG Si/C + MEG + APTES + 

















ade of hCG  
[45] 
Genetics DNA SiO2/Si + MG + PASE-




–  [46] 
Immunity IgG SiO2/Si + TRGO + 
AuNPs + anti-IgG 
2ng/mL up to 
0.02mg/mL 
SP – 68% 
[47] 
Immunity IgG SiO2/Si + PECVD-VG + 
AuNPs + anti-IgG 
2ng/mL SP – 9.8% 
SE – up to 
15% 
[48] 
Immunity IgG SiO2/Si + APTES + RGO 
in flake form + PtNPs + 
(CS2 + Protein G) 
Drain current decreased 
one order of magnitude 
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The foregoing shows that significant research progress has been made so far towards diagnostics for 
POC settings. However, there remains a huge gap in going beyond proof-of-concepts to commercially 
viable devices i.e. building holistic sensors. Attention must also be given to ensuring accuracy of results 
and not just sensitivity, specificity, detection limit and other performance metrics.  
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